TY - JOUR
T1 - Calcium phosphate microcrystals in the renal tubular fluid accelerate chronic kidney disease progression
AU - Shiizaki, Kazuhiro
AU - Tsubouchi, Asako
AU - Miura, Yutaka
AU - Seo, Kinya
AU - Kuchimaru, Takahiro
AU - Hayashi, Hirosaka
AU - Iwazu, Yoshitaka
AU - Miura, Marina
AU - Battulga, Batpurev
AU - Ohno, Nobuhiko
AU - Hara, Toru
AU - Kunishige, Rina
AU - Masutani, Mamiko
AU - Negishi, Keita
AU - Kario, Kazuomi
AU - Kotani, Kazuhiko
AU - Yamada, Toshiyuki
AU - Nagata, Daisuke
AU - Komuro, Issei
AU - Itoh, Hiroshi
AU - Kurosu, Hiroshi
AU - Murata, Masayuki
AU - Kuro-o, Makoto
N1 - Funding Information:
The authors thank Yukinari Ohsaka, Yuko Shimizu, and Taeko Yamauchi (Division of Anti-aging Medicine, Jichi Medical University), Tom Kouki and Megumi Yatabe (Department of Anatomy, Jichi Medical University), and Yuka Hara (National Institute for Materials Science) for their technical assistance; Kyoko Nakamu-ra (Division of Anti-aging Medicine, Jichi Medical University) for administrative assistance; and Satoshi Nishimura (Division of Anti-aging Medicine, Jichi Medical University) for help with ex vivo imaging. We also thank Kishiko Osaka and Naomi Okamo-to (University of Tokyo) for assistance with experiments; Orson Moe, Ming-Chang Hu, Johanne Pastor, and Charles Pak (University of Texas Southwestern Medical Center) for helpful discussions. This work was supported in part by funding from the NIH (R01AG19712 and R01 DK091392, to MK); Japan Agency for Medical Research and Development-Core Research for Evolutional Science and Technology (JP19gm0610012, to MK); the Japan Society for the Promotion of Science KAKENHI (JP16K08941, to YI, JP15K09269, to K Shiizaki, and JP20K21506, to NO); a Grant-in-Aid for Scientific Research on Innovative Areas (17H05870, to M. Murata); the Project for Cancer Research and Therapeutic Evolution (19cm0106110h0004, to M. Murata); the JST-Mirai Program (JPMJMI19G5, to M. Murata); and Bayer Japan (to MK).
Publisher Copyright:
Copyright: © 2021, American Society for Clinical Investigation.
PY - 2021/8/16
Y1 - 2021/8/16
N2 - The Western pattern diet is rich not only in fat and calories but also in phosphate. The negative effects of excessive fat and calorie intake on health are widely known, but the potential harms of excessive phosphate intake are poorly recognized. Here, we show the mechanism by which dietary phosphate damages the kidney. When phosphate intake was excessive relative to the number of functioning nephrons, circulating levels of FGF23, a hormone that increases the excretion of phosphate per nephron, were increased to maintain phosphate homeostasis. FGF23 suppressed phosphate reabsorption in renal tubules and thus raised the phosphate concentration in the tubule fluid. Once it exceeded a threshold, microscopic particles containing calcium phosphate crystals appeared in the tubule lumen, which damaged tubule cells through binding to the TLR4 expressed on them. Persistent tubule damage induced interstitial fibrosis, reduced the number of nephrons, and further boosted FGF23 to trigger a deterioration spiral leading to progressive nephron loss. In humans, the progression of chronic kidney disease (CKD) ensued when serum FGF23 levels exceeded 53 pg/mL. The present study identified calcium phosphate particles in the renal tubular fluid as an effective therapeutic target to decelerate nephron loss during the course of aging and CKD progression.
AB - The Western pattern diet is rich not only in fat and calories but also in phosphate. The negative effects of excessive fat and calorie intake on health are widely known, but the potential harms of excessive phosphate intake are poorly recognized. Here, we show the mechanism by which dietary phosphate damages the kidney. When phosphate intake was excessive relative to the number of functioning nephrons, circulating levels of FGF23, a hormone that increases the excretion of phosphate per nephron, were increased to maintain phosphate homeostasis. FGF23 suppressed phosphate reabsorption in renal tubules and thus raised the phosphate concentration in the tubule fluid. Once it exceeded a threshold, microscopic particles containing calcium phosphate crystals appeared in the tubule lumen, which damaged tubule cells through binding to the TLR4 expressed on them. Persistent tubule damage induced interstitial fibrosis, reduced the number of nephrons, and further boosted FGF23 to trigger a deterioration spiral leading to progressive nephron loss. In humans, the progression of chronic kidney disease (CKD) ensued when serum FGF23 levels exceeded 53 pg/mL. The present study identified calcium phosphate particles in the renal tubular fluid as an effective therapeutic target to decelerate nephron loss during the course of aging and CKD progression.
UR - http://www.scopus.com/inward/record.url?scp=85111672095&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85111672095&partnerID=8YFLogxK
U2 - 10.1172/JCI145693
DO - 10.1172/JCI145693
M3 - Article
C2 - 34185705
AN - SCOPUS:85111672095
SN - 0021-9738
VL - 131
JO - Journal of Clinical Investigation
JF - Journal of Clinical Investigation
IS - 16
M1 - e145693
ER -